The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: Cleavage is not required for infectivity

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9427-9433

  Bos, Evelyne C W ^a   Luytjes, Willem ^a   Spaan, Willy J M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VITRONECTIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUSION; GENE EXPRESSION; HEPATITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TARGET CELL; VIRION; VIRUS PARTICLE;

EID: 0030774237     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9427-9433.1997     Document Type: Article

References (54)

1. Blumberg, B. M., C. Giorgi, K. Rose, and D. Kolakofski. 1985. Sequence determination of the Sendai virus fusion protein gene. J. Gen. Virol. 66:317-331.
2. Bos, E. C. W., L. Heijnen, W. Luytjes, and W. J. M. Spaan. 1995. Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology 214:453-463.
3. Bos, E. C. W., W. Luytjes, H. Van der Meulen. H. K. Koerten, and W. J. M. Spaan. 1996. The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology 218:52-60.
4. Bredenbeek, P. 1990. Nucleic acid domains and proteins involved in the replication of coronaviruses. Ph.D. thesis. University of Utrecht, Utrecht, The Netherlands.
5. Chang, R. Y., M. A. Hofmann, P. B. Sethna, and D. A. Brian. 1994. A cis-acting function for the coronavirus leader in defective interfering RNA replication. J. Virol. 68:8223-8231.
6. Collins, A. R., R. L. Knobler, H. Powell, and M. J. Buchmeier. 1982. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119: 358-371.
7. Dveksler, G. S., M. N. Pensiero, C. B. Cardelechio, R. K. Williams, G. S. Jiang, K. V. Holmes, and C. W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
8. Dveksler, G. S., M. N. Pensiero, C. W. Dieffenbach, C. B. Cardelechio, A. A. Basile, P. E. Elia, and K. V. Holmes. 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA 90:1716-1720.
9. Frana, M. F., J. N. Behnke, L. S. Sturman, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 56:912-920.
10. Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87:4650-4654.
11. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike protein. J. Virol. 65:1916-1928.
12. Gallagher, T. M., M. J. Buchmeier, and S. Perlman. 1992. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology 191: 517-522.
13. Gallagher, T. M. 1996. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:4683-4690.
14. Gallaher, W. R. 1987. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 50:327-328.
15. Garroff, H., A.-M. Frischauf, K. Simons, H. Lehrbach, and H. Delius. 1980. Nucleotide sequence of cDNA coding for Semliki Forest virus membrane proteins. Nature 288:236-241.
16. Gething, M. J., R. W. Doms, D. York, and J. White. 1986. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:11-23.
17. Gilmore, W., J. O. Fleming, S. A. Stohlman, and L. P. Weiner. 1987. Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc. Soc. Exp. Biol. Med. 185:177-186.
18. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike cleavage signal. J. Virol. 67:4504-4512.
19. Grosse, B., and S. G. Siddell. 1994. Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1 subunit-specific monoclonal antibody. Virology 202:814-824.
20. Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:627-661.
21. Hingley, S. T., J. L. Gombold, E. Lavi, and S. R. Weiss. 1994. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology 200:1-10.
22. Holmes, K. V., E. W. Doller, and L. S. Sturman. 1981. Tunicamycine resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology 115:334-344.
23. Holmes, K. V., J. F. Boyle, R. K. Williams, C. B. Stephensen, S. G. Robbins, E. C. Bouer, C. S. Duchala, M. F. Frana, D. G. Weismiller, S. Compton, J. J. McGowan, and L. S. Sturman. 1987. Processing of coronavirus proteins and assembly of virions, p. 339-349. In M. A. Brinton and R. R. Rueckert (ed.), Positive strand RNA viruses. Alan R. Liss, Inc., New York, N.Y.
24. Kim, K. H., K. Narayanan, and S. Makino. 1997. Assembled coronavirus from complementation of two defective interfering RNAs. J. Virol. 71:3922-3931.
25. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
26. Luytjes, W., L. S. Sturman, P. J. Bredenbeek, J. Charite, B. A. M. van der Zeijst, M. C. Horzinek, and W. J. M. Spaan. 1987. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology 161:479-487.
27. Luytjes, W., H. Gerritsma, E. Bos, and W. J. M. Spaan. 1997. Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein. J. Virol. 71:949-955.
28. Makino, S., and M. M. C. Lai. 1989. High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J. Virol. 63: 5285-5292.
29. Masters, P. S., C. A. Koetzner, C. A. Kerr, and Y. Heo. 1994. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 68:328-337.
30. Meinkoth, J., and G. Wahl. 1984. Hybridization of nucleic acids immobilized on solid supports. Anal. Biochem. 138:267-284.
31. Niemann, H., and H. D. Klenk. 1981. Coronavirus glycoprotein E1, a new type of viral glycoprotein. J. Mol. Biol. 153:993-1010.
32. Opstelten D.-J. E., P. De Groote, M. C. Horzinek, H. Vennema, and P. J. M. Rottier. 1993. Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J. Virol. 67:7394-7401.
33. Peng, D., C. A. Koetzner, T. McMahon, Y. Zhu, and P. S. Masters. 1995. Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins. J. Virol. 69:5475-5484.
34. Ricard, C. S., and L. S. Sturman. 1985. Isolation of the subunits of the coronavirus envelope glycoprotein by hydroxyapatite high-performance liquid chromatography. J. Chromatogr. 326:191-197.
35. Ricard, C. S., C. A. Koetzner, L. S. Sturman, and P. S. Masters. 1995. A conditional-lethal coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions. Virus Res. 39:261-276.
36. Rottier, P. J. M., M. C. Horzinek, and B. A. M. Van der Zeijst. 1981. Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J. Virol. 40:350-357.
37. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
38. Schmidt, M. F. G. 1982. Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses. Virology 116:327-338.
39. Snijder, E. J., A. L. M. Wassenaar, and W. J. M. Spaan. 1994. Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J. Virol. 68:5755-5764.
40. Spaan, W. J. M., P. J. M. Rottier, M. C. Horzinek, and B. A. M. van der Zeijst. 1981. Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59). Virology 108:424-434.
41. Stauber, R., M. Pfleiderer, and S. Siddell. 1993. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion. J. Gen. Virol. 74:183-191.
42. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
43. Taguchi, F., T. Ikeda, and H. Shida. 1992. Molecular cloning and expression of a spike protein of neurovirulent murine cornavirus JHMV variant cl-2. J. Gen. Virol. 73:1065-1072.
44. Taguchi, F. 1993. Fusion formation by the uncleaved spike protein of murine coronavirus JHM variant cl-2. J. Virol. 67:1195-1202.
45. Van Berlo, M. F., W. J. Van den Brink, M. C. Horzinek, and B. A. M. Van der Zeijst. 1987. Fatty acid acylation of viral proteins in murine hepatitis virus-infected cells: brief report. Arch. Virol. 95:123-128.
46. Van der Most, R. G. P. J. Bredenbeek, and W. J. M. Spaan. 1991. A domain at the 3′ end of the polymerase gene is essential for the encapsidation of coronavirus defective interfering RNAs. J. Virol. 65:3219-3226.
47. Van der Most, R. G., L. Heijnen, W. J. M. Spaan, and R. J. de Groot. 1992. Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs. Nucleic Acids Res. 20:3375-3381.
48. Vennema, H., L. Heijnen, A. Zijderveld, M. C. Horzinek, and W. J. M. Spaan. 1990. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J. Virol. 64:339-346.
49. Vennema, H., R. Rijnbrand, L. Heijnen, M. C. Horzinek, and W. J. M. Spaan. 1991. Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system with encephalomyocarditis virus 5′ untranslated region sequences. Gene 108:201-210.
50. Vennema, H., G. J. Godeke, J. W. A. Rossen, W. F. Voorhout, M. C. Horzinek, D. J. E. Opstelten, and P. J. M. Rottier. 1996. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15:2020-2028.
51. Williams, R. K., G.-S. Jiang, S. W. Snyder, M. F. Frana, and K. V. Holmes. 1990 Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a non-functional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64: 3817-3823.
52. Williams, R. K., G.-S. Jiang, and K. V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
53. Yamada, Y. K., K. Takimoto, M. Yabe, and F. Taguchi. 1997. Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology 227:215-219.
54. Zhang, L., W. Luytjes, F. Homberger, and W. J. M. Spaan. 1997. Recombinant genomic RNA of coronavirus MHV-A59 after coreplication with a DI RNA containing the MHV RI spike gene. Virology 230:93-102.